List of Figures:
Figure 1. Research Method Flow Chart 10
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 13
Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 15
Figure 4. Asia Pacific Onychomycosis Treatment Market, 2021-2031, $ mn 17
Figure 5. Impact of COVID-19 on Business 20
Figure 6. Primary Drivers and Impact Factors of Asia Pacific Onychomycosis Treatment Market 22
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 26
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060 27
Figure 9. Primary Restraints and Impact Factors of Asia Pacific Onychomycosis Treatment Market 29
Figure 10. Investment Opportunity Analysis 33
Figure 11. Porter’s Fiver Forces Analysis of Asia Pacific Onychomycosis Treatment Market 36
Figure 12. Breakdown of Asia Pacific Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, % of Revenue 41
Figure 13. Asia Pacific Addressable Market Cap in 2022-2031 by Onychomycosis Type, Value ($ mn) and Share (%) 41
Figure 14. Asia Pacific Onychomycosis Treatment Market by Onychomycosis Type: Distal Subungual Onychomycosis, 2021-2031, $ mn 42
Figure 15. Asia Pacific Onychomycosis Treatment Market by Onychomycosis Type: White Superficial Onychomycosis, 2021-2031, $ mn 43
Figure 16. Asia Pacific Onychomycosis Treatment Market by Onychomycosis Type: Proximal Subungual Onychomycosis, 2021-2031, $ mn 44
Figure 17. Asia Pacific Onychomycosis Treatment Market by Onychomycosis Type: Candidal Onychomycosis, 2021-2031, $ mn 45
Figure 18. Asia Pacific Onychomycosis Treatment Market by Onychomycosis Type: Other Onychomycosis Types, 2021-2031, $ mn 46
Figure 19. Breakdown of Asia Pacific Onychomycosis Treatment Market by Treatment Type, 2021-2031, % of Sales Revenue 48
Figure 20. Asia Pacific Addressable Market Cap in 2022-2031 by Treatment Type, Value ($ mn) and Share (%) 48
Figure 21. Asia Pacific Onychomycosis Treatment Market by Treatment Type: Drug Treatment, 2021-2031, $ mn 49
Figure 22. Asia Pacific Onychomycosis Treatment Market by Treatment Type: Laser Therapy, 2021-2031, $ mn 50
Figure 23. Asia Pacific Onychomycosis Treatment Market by Treatment Type: Photodynamic Therapy, 2021-2031, $ mn 51
Figure 24. Asia Pacific Onychomycosis Treatment Market by Treatment Type: Other Therapies, 2021-2031, $ mn 52
Figure 25. Breakdown of Asia Pacific Onychomycosis Treatment Market by Distribution Channel, 2021-2031, % of Sales Revenue 54
Figure 26. Asia Pacific Addressable Market Cap in 2022-2031 by Distribution Channel, Value ($ mn) and Share (%) 54
Figure 27. Asia Pacific Onychomycosis Treatment Market by Distribution Channel: Hospitals and Clinics, 2021-2031, $ mn 55
Figure 28. Asia Pacific Onychomycosis Treatment Market by Distribution Channel: Online Stores, 2021-2031, $ mn 56
Figure 29. Asia Pacific Onychomycosis Treatment Market by Distribution Channel: Retail Pharmacies, 2021-2031, $ mn 57
Figure 30. Asia Pacific Onychomycosis Treatment Market by Distribution Channel: Other Distribution Channels, 2021-2031, $ mn 58
Figure 31. Breakdown of APAC Onychomycosis Treatment Market by Country, 2021 and 2031, % of Revenue 60
Figure 32. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 61
Figure 33. Onychomycosis Treatment Market in Japan, 2021-2031, $ mn 63
Figure 34. Onychomycosis Treatment Market in China, 2021-2031, $ mn 65
Figure 35. Onychomycosis Treatment Market in Australia, 2021-2031, $ mn 67
Figure 36. Onychomycosis Treatment Market in India, 2021-2031, $ mn 69
Figure 37. Onychomycosis Treatment Market in South Korea, 2021-2031, $ mn 71
Figure 38. Onychomycosis Treatment Market in Rest of APAC, 2021-2031, $ mn 73
Figure 39. Growth Stage of Asia Pacific Onychomycosis Treatment Industry over the Forecast Period 75
Asia Pacific onychomycosis treatment market will grow by 9.3% annually with a total addressable market cap of $10,998.9 million over 2022-2031, driven by the increasing prevalence of chronic medical ailments, the growing geriatric population, improved therapies and preventative solutions, and the rising healthcare expenditure. Highlighted with 28 tables and 39 figures, this 93-page report “Asia Pacific Onychomycosis Treatment Market 2021-2031 by Onychomycosis Type (Distal Subungual, White Superficial, Proximal Subungual, Candidal, Others), Treatment Type (Drug Treatment, Laser Therapy, Photodynamic Therapy, Others), Distribution Channel (Hospitals and Clinics, Online Stores, Retail Pharmacies, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific onychomycosis treatment market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and the Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific onychomycosis treatment market in every aspect of the classification from perspectives of Onychomycosis Type, Treatment Type, Distribution Channel, and Country. Based on Onychomycosis Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Distal Subungual Onychomycosis • White Superficial Onychomycosis • Proximal Subungual Onychomycosis • Candidal Onychomycosis • Other Onychomycosis Types Based on Treatment Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Drug Treatment • Laser Therapy • Photodynamic Therapy • Other Therapies By Distribution Channel, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Hospitals and Clinics • Online Stores • Retail Pharmacies • Other Distribution Channels Geographically, the following national/local markets are fully investigated: • Japan • China • South Korea • Australia • India • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Onychomycosis Type, Treatment Type and Distribution Channel over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Bausch Health Companies Inc. Bayer AG Cipla Ltd Dr. Reddys Laboratories Ltd Galderma SA GlaxoSmithKline PLC Johnson & Johnson Lumenis Ltd Medimetriks Pharmaceuticals Inc. Moberg Pharma AB Novartis AG Pfizer Inc. Sanofi SA (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Read More